T-Fovir A Tablet 25 mg contains Tenofovir Alafenamide, an advanced antiviral medication used in the treatment of chronic Hepatitis B virus (HBV) infection and as part of combination therapy for Human Immunodeficiency Virus (HIV-1) infection. It belongs to the class of nucleotide reverse transcriptase inhibitors (NRTIs) and is designed to effectively suppress viral replication with improved safety on kidneys and bones compared to older formulations.

Tenofovir Alafenamide is a prodrug of tenofovir that delivers higher concentrations of the active drug directly inside infected cells while maintaining lower levels in the bloodstream. This targeted delivery allows effective viral suppression at a lower dose, reducing the risk of certain systemic side effects.

T-Fovir A Tablet 25 mg plays a vital role in long-term antiviral therapy by lowering viral load, slowing disease progression, and reducing the risk of complications associated with chronic hepatitis B and HIV infection. Although it does not cure these viral infections, it helps maintain viral suppression and improves overall clinical outcomes when taken regularly as prescribed.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

T-Fovir A Tablet 25 mg is indicated for:

• Treatment of chronic hepatitis B infection in adults and adolescents

• Treatment of HIV-1 infection as part of combination antiretroviral therapy

For HIV treatment, Tenofovir Alafenamide must be used with other appropriate antiretroviral agents to ensure effective viral control and prevent resistance.

Dosage and Administration

The recommended dose of T-Fovir A Tablet 25 mg is usually one tablet once daily, taken with food or as directed by a registered healthcare professional. Taking the medicine at the same time each day helps maintain consistent drug levels in the body.

Patients are advised not to skip doses, as missed doses may reduce treatment effectiveness and increase the risk of viral resistance. Regular monitoring of liver and kidney function may be recommended during therapy.

Benefits and Features

• Effective antiviral action against hepatitis B and HIV-1

• Lower risk of kidney and bone toxicity compared to older tenofovir formulations

• Once-daily convenient dosing

• Maintains long-term viral suppression

• Suitable for chronic management under medical supervision

Precautions and Warnings

Before starting T-Fovir A Tablet, inform the physician about any history of liver disease, kidney problems, or bone disorders. Patients with hepatitis B should not stop the medication without medical advice, as abrupt discontinuation may lead to severe worsening of hepatitis.

Caution is advised when used in combination with other medications that may affect kidney function. Regular follow-up and laboratory monitoring are important to ensure safe and effective treatment.

Pregnant or breastfeeding women should consult a healthcare provider before use.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

T-Fovir A Tablet is generally well tolerated. Common side effects may include:

• Headache

• Nausea

• Fatigue

• Abdominal discomfort

Serious side effects are rare but may include lactic acidosis or liver-related complications. Any unusual or persistent symptoms should be reported promptly.

Storage

Store T-Fovir A Tablet 25 mg in a cool, dry place away from moisture and direct sunlight. Keep out of reach of children.

T-Fovir A Tablet 25 mg (Tenofovir Alafenamide) offers effective and safer long-term antiviral therapy for chronic hepatitis B and HIV infection, supporting sustained viral suppression and improved patient outcomes when used as prescribed.